Adjust Font Increase Font Decrease Font
  • Email
  • Print
  • RSS Feed

The Catalyst

by John Castellani on 2/21/2012

PhRMA CEO John J. CastellaniComing to work at PhRMA a year and a half ago required a bit of a crash course in the incredibly complex and always evolving biopharmaceutical research sector. In that time, I’ve come to learn that many industry critics seek to generalize (and sometimes mischaracterize) the development of new medicines, our sector’s commitment to safety and the role of investment. And if one thing is true about biopharmaceutical research, it’s that the...

Recent Posts

by John Castellani on 2/21/2012

PhRMA CEO John J. CastellaniComing to work at PhRMA a year and a half ago required a bit of a crash course in the incredibly complex and always evolving biopharmaceutical research sector. In that time, I’ve come to learn that many...

by Kate Connors on 2/20/2012

Late Friday afternoon, PhRMA submitted our comments to the Centers for Medicare and Medicaid Services about the agency's proposed rule for implementation of the Physician Payment Sunshine provision of the Affordable Care Act.

That's a mouthful - and so are our comments (we released a statement which links...

by Grady Forrer on 2/16/2012

Take a look at John Allen Paulos’ recent opinion piece in the February 13 New York Times. In Why Don’t Americans Elect More Scientists, Paulos looks at the lack of scientists and trained experts serving in Congress and the highest levels of...

by Jennifer Wall on 2/15/2012

To help keep Catalyst readers well-informed with the latest news, I want to bring to your attention that a fake cancer drug is circulating in the U.S. drug supply system. According to press reports, the maker of the drug is not yet aware of how the counterfeit medicine got in the supply...

by Grady Forrer on 2/13/2012

This is for the foodies out there…

Ok, so it is pretty well established that innovative medicines have dramatically changed and improved healthcare over the last 50 years. But we always need to keep in mind that medicines are but one piece of the healthcare puzzle and that nutrition, genetics, life-style, access to treatment, adherence to treatments – among other factors – also play an important role in achieving and maintaining good health.   I did...

by Karl Uhlendorf on 2/10/2012

As you all know, one of PhRMA’s main purposes is to advocate for policies that help foster the discovery of new medicines for patients. In doing so, we often slip into the inside-the-beltway vernacular of legislation, guidances and rulemakings, backing up our positions with stats, scores and citations. All of which can sometimes be a bit impersonal (though less so in The Catalyst).

And then there are times when these policies and laws really hit home.

In an...

by Kate Connors on 2/10/2012

A few days ago, I missed an op-ed in the Washington Times that I just came across today – and I’m glad I did.

In recent years, we have seen both the advent of online health information and an increase in use of health IT. These tools have dramatically improved the ability of healthcare stakeholders, including patients, to communicate with each other...

by Jennifer Wall on 2/9/2012

I really never had the interest to live in California until my husband and I visited the Golden State a few years ago. It wasn’t until our drive up Route 1 from Santa Barbara to San Francisco did I change my mind. Driving up the Pacific Coast Highway was literally a life-changing experience. We’d often pull over to the side of the road to take in the beautiful scenery – the ocean, the rolling hills and the sea lions (not to mention the great vineyards). Oh, how I miss thee...

by Kate Connors on 2/9/2012

This week’s White House Science Fair rightly honored scientific achievement by inviting some remarkable young students to demonstrate the advances that they have made.

Sugar packets that dissolve in hot water, avoiding waste? Why didn’t I think of that? Robots that operate like Skype, so grandchildren can even more closely communicate with their distant grandparents? Imagine what that would mean to families.

It’s promising to see the Administration honoring...

by Preet Bilinski on 2/8/2012

The PhRMA Foundation recently announced its 2012 award recipients and one, Lindsay Garvin, is right in our backyard from the George Washington University’s School of Medicine and Health Sciences. She is a doctoral candidate pursuing a Ph.D...

by Jennifer Wall on 2/7/2012

The White House today unveiled new efforts to help fight Alzheimer’ disease, including providing additional funding for research, caregiver support and provider education.

We share the same goal as the Administration – we want to put an end to the devastating toll this disease has on patients, their caregivers and even the U.S. health care system. If you didn’t already know,...

by Kate Connors on 2/7/2012

In the coming weeks and months, we’re hoping to have some contributions to The Catalyst by PhRMA President and CEO John Castellani. Some of them may be quick interviews with me, and some may be thoughts that he wants to put down on paper.

To that end, I’d like to hear what our Catalyst readers would like to hear John discuss. Leave your comments below or Tweet me @KateAtPhRMA.

I can’t promise he...

by Grady Forrer on 2/2/2012

There’s a potentially very exciting story in today’s New York Times that’s worth a look. Researchers doing mouse studies have apparently learned some important new information about how Alzheimer’s disease spreads in the brain. Specifically, what apparently surprised the researchers is that Alzheimer’s disease...

by Preet Bilinski on 2/1/2012

If not, don’t worry: you are not alone. However, considering that more than 13 million Americans suffer from the disease and an additional 12 million likely have it without knowing it, it’s time to learn.

copd

Chronic obstructive pulmonary disease (COPD) is one of the most common lung diseases in the U.S. COPD is a progressive lower respiratory disease that encompasses two...

by Jennifer Wall on 2/1/2012

I was just getting my daily dose of pharma news from Pharmalot and ran across an interesting blog post about prescribing decisions made by doctors. Ed Silverman, the man behind Pharmalot, highlighted a recent study that examined how a group of physicians view the prescribing of generic drugs. While many of the physicians reported...